High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial

International Journal of Antimicrobial Agents

January 6, 2022

10.1016/j.ijantimicag.2021.106516

Cited by 58

Related Papers

No related papers found

Powered by citation graph analysis